Literature DB >> 26133521

Intraoperative electron-beam radiation therapy with or without external-beam radiotherapy in the management of paraaortic lymph-node oligometastases from gynecological malignancies.

C V Sole1,2, F A Calvo3,4,5, S Lizarraga3,5, L Gonzalez-Bayon3,5,6, J L García-Sabrido3,5,6.   

Abstract

PURPOSE: To analyze long-term outcomes and prognostic factors in patients with paraaortic lymph-node oligometastases (LNO) from gynecological malignancies treated in a multimodal protocol.
METHODS: Patients with a histological diagnosis of LNO gynecological cancer [uterine cervix (n = 14, 40 %), endometrial (n = 18, 51 %), ovarian (n = 3, 9 %)] who underwent surgery with radical intent and intraoperative radiotherapy (IORT), median dose 12.5 Gy) were considered eligible for participation in this study. Additionally, 51 % received external-beam radiotherapy (EBRT).
RESULTS: From 1997 to 2012, a total of 35 patients from a single institution were analyzed. With a median follow-up time of 55 months (range 2-148), 5-year loco-regional control (LRC), disease-free survival (DFS) and overall survival (OS) were 79, 44 and 49 %, respectively. On multivariate analysis, no EBRT treatment to the LNO (p = 0.03), and time interval from primary tumor diagnosis to LNO <24 months (p = 0.04) remained significantly associated with locoregional recurrence (LRR). We found on multivariate analysis that only R1 margin status (p = 0.01) was significantly associated with OS.
CONCLUSION: From the current series of patients with gynecological LNO, it emerges the fact that EBRT promotes local control. Future prospective studies might be designed according to the predicted risk of LRR focusing on different subgroups.

Entities:  

Keywords:  External-beam radiotherapy; Long-term outcomes; Lymph-node oligometastases

Mesh:

Year:  2015        PMID: 26133521     DOI: 10.1007/s12094-015-1326-7

Source DB:  PubMed          Journal:  Clin Transl Oncol        ISSN: 1699-048X            Impact factor:   3.405


  12 in total

1.  An innovative tool for intraoperative electron beam radiotherapy simulation and planning: description and initial evaluation by radiation oncologists.

Authors:  Javier Pascau; Juan Antonio Santos Miranda; Felipe A Calvo; Ana Bouché; Virgina Morillo; Carmen González-San Segundo; Carlos Ferrer; Juan López Tarjuelo; Manuel Desco
Journal:  Int J Radiat Oncol Biol Phys       Date:  2012-03-06       Impact factor: 7.038

2.  Intraoperative radiation therapy in recurrent carcinoma of the uterine cervix: report of the French intraoperative group on 70 patients.

Authors:  M A Mahé; J P Gérard; J B Dubois; A Roussel; E Bussières; M Delannes; F Guillemin; T Schmitt; D Dargent; Y Guillard; P Martel; P Richaud; J C Cuillière; J De Ranieri; L Malissard
Journal:  Int J Radiat Oncol Biol Phys       Date:  1996-01-01       Impact factor: 7.038

3.  Radical pelvic resection and intraoperative radiation therapy for recurrent endometrial cancer: technique and analysis of outcomes.

Authors:  Sean C Dowdy; Andrea Mariani; William A Cliby; Michael G Haddock; Ivy A Petersen; Franklin H Sim; Karl C Podratz
Journal:  Gynecol Oncol       Date:  2006-05       Impact factor: 5.482

Review 4.  The oligometastatic state - separating truth from wishful thinking.

Authors:  David A Palma; Joseph K Salama; Simon S Lo; Suresh Senan; Tom Treasure; Ramaswamy Govindan; Ralph Weichselbaum
Journal:  Nat Rev Clin Oncol       Date:  2014-06-24       Impact factor: 66.675

5.  Toxicity criteria of the Radiation Therapy Oncology Group (RTOG) and the European Organization for Research and Treatment of Cancer (EORTC)

Authors:  J D Cox; J Stetz; T F Pajak
Journal:  Int J Radiat Oncol Biol Phys       Date:  1995-03-30       Impact factor: 7.038

6.  Intraoperative electron beam radiotherapy during radical surgery for locally advanced and recurrent cervical cancer.

Authors:  R Martínez-Monge; M Jurado; J J Aristu; M Moreno; M Cambeiro; A Pérez-Ochoa; G López-García; J L Alcazar
Journal:  Gynecol Oncol       Date:  2001-09       Impact factor: 5.482

Review 7.  Oligometastases revisited.

Authors:  Ralph R Weichselbaum; Samuel Hellman
Journal:  Nat Rev Clin Oncol       Date:  2011-03-22       Impact factor: 66.675

8.  Intraoperative radiation therapy in gynecologic cancer: update of the experience at a single institution.

Authors:  G R Garton; L L Gunderson; M J Webb; T O Wilson; S S Cha; K C Podratz
Journal:  Int J Radiat Oncol Biol Phys       Date:  1997-03-01       Impact factor: 7.038

Review 9.  Oligometastases and oligo-recurrence: the new era of cancer therapy.

Authors:  Yuzuru Niibe; Kazushige Hayakawa
Journal:  Jpn J Clin Oncol       Date:  2010-01-04       Impact factor: 3.019

10.  Intraoperative Electron Beam Radiotherapy (IOERT) in the management of locally advanced or recurrent cervical cancer.

Authors:  Brandon M Barney; Ivy A Petersen; Sean C Dowdy; Jamie N Bakkum-Gamez; Kristi A Klein; Michael G Haddock
Journal:  Radiat Oncol       Date:  2013-04-08       Impact factor: 3.481

View more
  1 in total

1.  CT-guided 125I brachytherapy for recurrent ovarian cancer.

Authors:  Ping Liu; Lina Tong; Bin Huo; Dong Dai; Wenxin Liu; Ke Wang; Ying Wang; Zhi Guo; Hong Ni
Journal:  Oncotarget       Date:  2017-03-04
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.